Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin H Kim

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Allergy and Clinical Immunology|February 24, 2023
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic childrenEdwin H Kim, Corinne A Keet, Yamini V Virkud, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Association of bile acids, amino acids, and glycerophospholipid metabolites with food-allergic outcomes in children on peanut oral immunotherapyJennifer N Styles, Justin K Wang, Ananya Raman, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2025
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE bindingJoshua S Bernstein, Nicole Canon, Catherine H Schein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 18, 2024
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH StudyBrian P Vickery, J Andrew Bird, R Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2023
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trialEdwin H Kim, J Andrew Bird, Corinne A Keet, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2013
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparisonStacy J Chin, Brian P Vickery, Michael D Kulis, et al.
Journal of Agricultural and Food Chemistry|February 2, 2023
Structure and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried PeptidesAlexander C Y Foo, Jacqueline B Nesbit, Stephen A Y Gipson, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapyMichael D Kulis, Johanna M Smeekens, Caitlin Burk, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 7, 2022
Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin-like 4 identified in orally susceptible peanut allergy modelErin C Steinbach, Johanna M Smeekens, Satyaki Roy, et al.
The Journal of Allergy and Clinical Immunology. Global|May 27, 2026
Irradiation does not impact the immunogenicity of food flours used for oral immunotherapyTimothy P Moran, Anusha Penumarti, Robert M Immormino, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Allergy and Clinical Immunology|February 24, 2023
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic childrenEdwin H Kim, Corinne A Keet, Yamini V Virkud, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Association of bile acids, amino acids, and glycerophospholipid metabolites with food-allergic outcomes in children on peanut oral immunotherapyJennifer N Styles, Justin K Wang, Ananya Raman, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2025
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE bindingJoshua S Bernstein, Nicole Canon, Catherine H Schein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 18, 2024
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH StudyBrian P Vickery, J Andrew Bird, R Sharon Chinthrajah, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2023
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trialEdwin H Kim, J Andrew Bird, Corinne A Keet, et al.
The Journal of Allergy and Clinical Immunology|March 29, 2013
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparisonStacy J Chin, Brian P Vickery, Michael D Kulis, et al.
Journal of Agricultural and Food Chemistry|February 2, 2023
Structure and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried PeptidesAlexander C Y Foo, Jacqueline B Nesbit, Stephen A Y Gipson, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Kinetics of basophil hyporesponsiveness during short-course peanut oral immunotherapyMichael D Kulis, Johanna M Smeekens, Caitlin Burk, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 7, 2022
Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin-like 4 identified in orally susceptible peanut allergy modelErin C Steinbach, Johanna M Smeekens, Satyaki Roy, et al.
The Journal of Allergy and Clinical Immunology. Global|May 27, 2026
Irradiation does not impact the immunogenicity of food flours used for oral immunotherapyTimothy P Moran, Anusha Penumarti, Robert M Immormino, et al.
Pageof 10